1280205-96-0 Usage
Uses
Used in Organic Synthesis:
[5-(4-bromo-phenyl)-3-methyl-isoxazol-4-yl]-carbamic acid tert-butyl ester is used as a reagent in organic synthesis for the creation of various complex organic molecules. Its unique structure allows for a range of reactions, making it a valuable tool in the synthesis of pharmaceuticals and other specialty chemicals.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, [5-(4-bromo-phenyl)-3-methyl-isoxazol-4-yl]-carbamic acid tert-butyl ester is employed as a key intermediate in the development of new drugs. Its structural properties enable researchers to explore its potential in targeting specific biological pathways and creating novel therapeutic agents.
Used in Pharmaceutical Development:
[5-(4-bromo-phenyl)-3-methyl-isoxazol-4-yl]-carbamic acid tert-butyl ester holds promise in the development of new pharmaceuticals. Its unique chemical structure can be modified and optimized to target specific diseases or conditions, potentially leading to the creation of more effective and safer medications.
Used in Agrochemical Development:
Similarly, [5-(4-bromo-phenyl)-3-methyl-isoxazol-4-yl]-carbamic acid tert-butyl ester may also find applications in the development of new agrochemicals, such as pesticides and herbicides. Its structural properties can be harnessed to create more targeted and environmentally friendly solutions for agricultural challenges.
Check Digit Verification of cas no
The CAS Registry Mumber 1280205-96-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,0,2,0 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1280205-96:
(9*1)+(8*2)+(7*8)+(6*0)+(5*2)+(4*0)+(3*5)+(2*9)+(1*6)=130
130 % 10 = 0
So 1280205-96-0 is a valid CAS Registry Number.
1280205-96-0Relevant academic research and scientific papers
LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
-
, (2013/03/26)
Compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat, prevent or diagnose diseases, disorders, or conditions associated with one or more of the lysophosphatidic acid receptors are provided.
LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
-
, (2012/10/18)
Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in com
POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
-
, (2011/04/24)
Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.
